DRIVIN G ROWTH - Dr. Reddy's
DRIVIN G ROWTH - Dr. Reddy's
DRIVIN G ROWTH - Dr. Reddy's
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
42<br />
directors’ report<br />
1<br />
| Electricity<br />
Purchased<br />
2<br />
|<br />
Coal<br />
Annexure to the directors’ report<br />
FORM A<br />
Form for Disclosure of Particulars with<br />
respect to Conservation of Energy.<br />
A. Power and fuel consumption<br />
CURRENT YEAR (2001-02) PREVIOUS YEAR (2000-01)<br />
Unit 49,099,022 43,564,664<br />
Total amount Rs. 202,287,970 Rs. 187,066,404<br />
Rate/unit Rs. 4.12 Rs. 4.29<br />
Own generation – through diesel generator set<br />
Unit 4,482,455 6,046,313<br />
Units per ltr. of diesel oil 3.32 3.38<br />
Cost/unit 5.11 Rs. 4.11<br />
(Used in boiler)<br />
CURRENT YEAR (2001-02) PREVIOUS YEAR (2000-01)<br />
Quantity (tonnes) 18,565 18,119<br />
Total Cost (Rs.) 41,350,970 28,363,241<br />
Average rate 2,227 1,565<br />
FORM B<br />
Research and Development (R & D)<br />
1.Specific areas in which R & D carried<br />
out by the Company.<br />
• Development of commercially viable<br />
processes for pharmaceutical products and<br />
new polymorphism with a good market<br />
potential worldwide<br />
• Development of alternate routes of<br />
DR. REDDY’S LABORATORIES LTD. | DIRECTORS’ REPORT | ANNUAL REPORT 2001-2002<br />
synthesis for products already<br />
commercialised. Study of impurity<br />
profiles of products<br />
• Development of non-infringing process,<br />
to become a API source for Generic<br />
customers<br />
• Product development of generic products<br />
for ANDA/Dossier submission and<br />
approval. Patent non-infringing<br />
technologies and patentable technologies<br />
for the regulated markets like USA,<br />
Europe<br />
• Novel <strong>Dr</strong>ug Delivery Systems<br />
• Analytical Research & Development<br />
including impurity identification,<br />
polymorph identification<br />
• Bio analytical research and development<br />
for the development of bio-equivalent<br />
products<br />
• Development of products for human care<br />
• Analytical methods development,<br />
• Quality improvements,<br />
• Alternate vendors development for<br />
existing materials,<br />
• Cost reduction and<br />
• Packaging development for new products,<br />
improvements in existing packs